These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 29739039)
1. Elevated TEAD1 Expression is not an Independent Prognosis Factor of Hepatocellular Carcinoma. Hu X; He B; Zhou L; Zheng S Clin Lab; 2018 May; 64(5):743-748. PubMed ID: 29739039 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic relevance of CP2c and YY1 expression in hepatocellular carcinoma. Kim JS; Son SH; Kim MY; Choi D; Jang IS; Paik SS; Chae JH; Uversky VN; Kim CG Oncotarget; 2017 Apr; 8(15):24389-24400. PubMed ID: 28412749 [TBL] [Abstract][Full Text] [Related]
3. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis. Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703 [TBL] [Abstract][Full Text] [Related]
4. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma. Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591 [TBL] [Abstract][Full Text] [Related]
5. Serine/arginine rich splicing factor 2 expression and clinic pathological features indicating a prognostic factor in human hepatocellular carcinoma patients. Wang P; Guo L; Li K; Ning S; Shi W; Liu Z; Chen Y Cancer Biomark; 2018 Feb; 21(3):681-687. PubMed ID: 29278882 [TBL] [Abstract][Full Text] [Related]
6. Combined aberrant expression of N-Myc downstream-regulated gene 2 and CD24 is associated with disease-free survival and overall survival in patients with hepatocellular carcinoma. Li B; Shao Q; Ji D; Li F; Guo X; Chen G Diagn Pathol; 2014 Oct; 9():209. PubMed ID: 25338637 [TBL] [Abstract][Full Text] [Related]
7. Expression of MSP58 in hepatocellular carcinoma. Zhong M; Zhang X; Li B; Chen CS; Ji GL; Li SX; Bi DQ; Zhao QC; Shi H Med Oncol; 2013 Jun; 30(2):539. PubMed ID: 23519485 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma. Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263 [TBL] [Abstract][Full Text] [Related]
9. MBD2 as a novel marker associated with poor survival of patients with hepatocellular carcinoma after hepatic resection. Liu W; Wang N; Lu M; Du XJ; Xing BC Mol Med Rep; 2016 Aug; 14(2):1617-23. PubMed ID: 27315121 [TBL] [Abstract][Full Text] [Related]
10. Tissue microarray-based study of hepatocellular carcinoma validating SPIB as potential clinical prognostic marker. Ho YJ; Lin YM; Huang YC; Yeh KT; Lin LI; Lu JW Acta Histochem; 2016 Jan; 118(1):38-45. PubMed ID: 26610895 [TBL] [Abstract][Full Text] [Related]
11. [Clinicopathological significance of ezrin and SIX1 protein expression in alpha fetoprotein-negative hepatocellular carcinoma]. Kong J; Zhou X; Han L; Quan C; Cui X; Lin Z Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):236-9. PubMed ID: 26927385 [TBL] [Abstract][Full Text] [Related]
12. Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma. Xu MZ; Yao TJ; Lee NP; Ng IO; Chan YT; Zender L; Lowe SW; Poon RT; Luk JM Cancer; 2009 Oct; 115(19):4576-85. PubMed ID: 19551889 [TBL] [Abstract][Full Text] [Related]
13. Downregulation of betaine homocysteine methyltransferase (BHMT) in hepatocellular carcinoma associates with poor prognosis. Jin B; Gong Z; Yang N; Huang Z; Zeng S; Chen H; Hu S; Pan G Tumour Biol; 2016 May; 37(5):5911-7. PubMed ID: 26592251 [TBL] [Abstract][Full Text] [Related]
14. The Prognostic Significance of NEK2 in Hepatocellular Carcinoma: Evidence from a Meta-Analysis and Retrospective Cohort Study. Cheng Y; Chen X; Ye L; Zhang Y; Liang J; Liu W; Zhou B; Zheng S; Huang Y; Chen G; Deng Y; Zhang Q; Yang Y Cell Physiol Biochem; 2018; 51(6):2746-2759. PubMed ID: 30562736 [TBL] [Abstract][Full Text] [Related]
15. Decreased Expression of ZWINT is Associated With Poor Prognosis in Patients With HCC After Surgery. Yang XY; Wu B; Ma SL; Yin L; Wu MC; Li AJ Technol Cancer Res Treat; 2018 Jan; 17():1533033818794190. PubMed ID: 30198401 [TBL] [Abstract][Full Text] [Related]
16. Tumor-associated autoantibodies are useful biomarkers in immunodiagnosis of α-fetoprotein-negative hepatocellular carcinoma. Wang T; Liu M; Zheng SJ; Bian DD; Zhang JY; Yao J; Zheng QF; Shi AM; Li WH; Li L; Chen Y; Wang JH; Duan ZP; Dong L World J Gastroenterol; 2017 May; 23(19):3496-3504. PubMed ID: 28596685 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of combining high mobility group Box-1 and OV-6 expression in hepatocellular carcinoma. Zhu J; Yu H; Chen S; Yang P; Dong Z; Ling Y; Tang H; Bai S; Yang W; Tang L; Shen F; Wang H; Wen W Sci China Life Sci; 2018 Aug; 61(8):912-923. PubMed ID: 29441453 [TBL] [Abstract][Full Text] [Related]
18. Expression and clinical significance of TAp73alpha, p53, PCNA and apoptosis in hepatocellular carcinoma. Qin HX; Nan KJ; Yang G; Jing Z; Ruan ZP; Li CL; Xu R; Guo H; Sui CG; Wei YC World J Gastroenterol; 2005 May; 11(18):2709-13. PubMed ID: 15884108 [TBL] [Abstract][Full Text] [Related]
19. Clinical value of apoptosis and angiogenesis factors in estimating the prognosis of hepatocellular carcinoma. Guo RP; Zhong C; Shi M; Zhang CQ; Wei W; Zhang YQ; Li JQ J Cancer Res Clin Oncol; 2006 Sep; 132(9):547-55. PubMed ID: 16763805 [TBL] [Abstract][Full Text] [Related]
20. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma. Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]